Hepavec Aktiengesellschaft Für Gentherapie
Latest round
- Series A
Last raised
- May 2000
Total raised
- $4.4M
Investors
- 5
About Hepavec Aktiengesellschaft Für Gentherapie
Founded in 1998 and based in Berlin, Germany, Hepavec Aktiengesellschaft Für Gentherapie researches and develops novel treatments for malignant and genetic liver diseases.
Who invested in Hepavec Aktiengesellschaft Für Gentherapie
5 investors across 1 round
See all investors in Hepavec Aktiengesellschaft Für Gentherapie
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 8, 2000
Amount
$4.4M
Investors
Questions about Hepavec Aktiengesellschaft Für Gentherapie
Who invested in Hepavec Aktiengesellschaft Für Gentherapie?
Hepavec Aktiengesellschaft Für Gentherapie has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Hepavec Aktiengesellschaft Für Gentherapie raised?
Hepavec Aktiengesellschaft Für Gentherapie has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Hepavec Aktiengesellschaft Für Gentherapie last raise money?
Hepavec Aktiengesellschaft Für Gentherapie's most recent round on record is a Series A, in May 2000.
What does Hepavec Aktiengesellschaft Für Gentherapie do?
Founded in 1998 and based in Berlin, Germany, Hepavec Aktiengesellschaft Für Gentherapie researches and develops novel treatments for malignant and genetic liver diseases.
Where is Hepavec Aktiengesellschaft Für Gentherapie headquartered?
Hepavec Aktiengesellschaft Für Gentherapie is headquartered in Berlin, Germany.
Which VCs invest in companies like Hepavec Aktiengesellschaft Für Gentherapie?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back pharmaceuticals companies at Hepavec Aktiengesellschaft Für Gentherapie's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Hepavec Aktiengesellschaft Für Gentherapie? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.